We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | NYSE:TEVA | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.21 | -1.61% | 12.80 | 13.0887 | 12.86 | 13.00 | 7,499,725 | 01:00:00 |
From Apr 2019 to Apr 2024
Data published by the National Multiple Sclerosis Society show that Biogen, along with rival companies such as Teva Pharmaceutical Industries and Novartis Pharmaceuticals, haven't been shy about raising the list prices of these medicines. "Biogen Treads Tricky Path Between Politicians, Investors," at 10:43 a.m. EDT, in the third paragraph incorrectly included Roche Pharmaceuticals among the companies that have raised the list prices of their multiple sclerosis medicines.
(END) Dow Jones Newswires
August 18, 2017 19:04 ET (23:04 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Teva Pharmaceutical Indu... Chart |
1 Month Teva Pharmaceutical Indu... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
